JP2017105859A5 - - Google Patents

Download PDF

Info

Publication number
JP2017105859A5
JP2017105859A5 JP2017061092A JP2017061092A JP2017105859A5 JP 2017105859 A5 JP2017105859 A5 JP 2017105859A5 JP 2017061092 A JP2017061092 A JP 2017061092A JP 2017061092 A JP2017061092 A JP 2017061092A JP 2017105859 A5 JP2017105859 A5 JP 2017105859A5
Authority
JP
Japan
Prior art keywords
osteoporosis
agent
prophylactic agent
bone
pth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017061092A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017105859A (ja
JP6274634B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2017105859A publication Critical patent/JP2017105859A/ja
Publication of JP2017105859A5 publication Critical patent/JP2017105859A5/ja
Application granted granted Critical
Publication of JP6274634B2 publication Critical patent/JP6274634B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017061092A 2009-09-09 2017-03-27 骨粗鬆症治療剤ないし予防剤 Active JP6274634B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2009208039 2009-09-09
JP2009208039 2009-09-09

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2016219323A Division JP2017061511A (ja) 2009-09-09 2016-11-10 １回当たり１００〜２００単位のｐｔｈが週１回投与されることを特徴とする、ｐｔｈ含有骨粗鬆症治療／予防剤

Publications (3)

Publication Number Publication Date
JP2017105859A JP2017105859A (ja) 2017-06-15
JP2017105859A5 true JP2017105859A5 (enExample) 2017-07-27
JP6274634B2 JP6274634B2 (ja) 2018-02-07

Family

ID=43732444

Family Applications (13)

Application Number Title Priority Date Filing Date
JP2011530844A Pending JPWO2011030774A1 (ja) 2009-09-09 2010-09-08 １回当たり１００〜２００単位のｐｔｈが週１回投与されることを特徴とする、ｐｔｈ含有骨粗鬆症治療／予防剤
JP2015105266A Active JP6198346B2 (ja) 2009-09-09 2015-05-25 １回当たり１００〜２００単位のｐｔｈが週１回投与されることを特徴とする、ｐｔｈ含有骨粗鬆症治療／予防剤
JP2015105265A Active JP6150846B2 (ja) 2009-09-09 2015-05-25 １回当たり１００〜２００単位のｐｔｈが週１回投与されることを特徴とする、ｐｔｈ含有骨粗鬆症治療／予防剤
JP2016082589A Active JP6043008B2 (ja) 2009-09-09 2016-04-18 １回当たり１００〜２００単位のｐｔｈが週１回投与されることを特徴とする、ｐｔｈ含有骨粗鬆症治療／予防剤
JP2016219323A Pending JP2017061511A (ja) 2009-09-09 2016-11-10 １回当たり１００〜２００単位のｐｔｈが週１回投与されることを特徴とする、ｐｔｈ含有骨粗鬆症治療／予防剤
JP2017061095A Withdrawn JP2017105862A (ja) 2009-09-09 2017-03-27 椎体骨折抑制剤
JP2017061096A Pending JP2017105863A (ja) 2009-09-09 2017-03-27 骨粗鬆症治療剤ないし予防剤
JP2017061094A Withdrawn JP2017105861A (ja) 2009-09-09 2017-03-27 骨粗鬆症治療剤ないし予防剤
JP2017061092A Active JP6274634B2 (ja) 2009-09-09 2017-03-27 骨粗鬆症治療剤ないし予防剤
JP2017061093A Active JP6301524B2 (ja) 2009-09-09 2017-03-27 骨粗鬆症治療剤ないし予防剤
JP2017061091A Active JP6275900B2 (ja) 2009-09-09 2017-03-27 骨粗鬆症治療剤ないし予防剤
JP2017221570A Active JP6522715B2 (ja) 2009-09-09 2017-11-17 １回当たり１００〜２００単位のｐｔｈが週１回投与されることを特徴とする、ｐｔｈ含有骨粗鬆症治療／予防剤
JP2018215152A Pending JP2019023234A (ja) 2009-09-09 2018-11-16 骨粗鬆症治療剤ないし予防剤

Family Applications Before (8)

Application Number Title Priority Date Filing Date
JP2011530844A Pending JPWO2011030774A1 (ja) 2009-09-09 2010-09-08 １回当たり１００〜２００単位のｐｔｈが週１回投与されることを特徴とする、ｐｔｈ含有骨粗鬆症治療／予防剤
JP2015105266A Active JP6198346B2 (ja) 2009-09-09 2015-05-25 １回当たり１００〜２００単位のｐｔｈが週１回投与されることを特徴とする、ｐｔｈ含有骨粗鬆症治療／予防剤
JP2015105265A Active JP6150846B2 (ja) 2009-09-09 2015-05-25 １回当たり１００〜２００単位のｐｔｈが週１回投与されることを特徴とする、ｐｔｈ含有骨粗鬆症治療／予防剤
JP2016082589A Active JP6043008B2 (ja) 2009-09-09 2016-04-18 １回当たり１００〜２００単位のｐｔｈが週１回投与されることを特徴とする、ｐｔｈ含有骨粗鬆症治療／予防剤
JP2016219323A Pending JP2017061511A (ja) 2009-09-09 2016-11-10 １回当たり１００〜２００単位のｐｔｈが週１回投与されることを特徴とする、ｐｔｈ含有骨粗鬆症治療／予防剤
JP2017061095A Withdrawn JP2017105862A (ja) 2009-09-09 2017-03-27 椎体骨折抑制剤
JP2017061096A Pending JP2017105863A (ja) 2009-09-09 2017-03-27 骨粗鬆症治療剤ないし予防剤
JP2017061094A Withdrawn JP2017105861A (ja) 2009-09-09 2017-03-27 骨粗鬆症治療剤ないし予防剤

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2017061093A Active JP6301524B2 (ja) 2009-09-09 2017-03-27 骨粗鬆症治療剤ないし予防剤
JP2017061091A Active JP6275900B2 (ja) 2009-09-09 2017-03-27 骨粗鬆症治療剤ないし予防剤
JP2017221570A Active JP6522715B2 (ja) 2009-09-09 2017-11-17 １回当たり１００〜２００単位のｐｔｈが週１回投与されることを特徴とする、ｐｔｈ含有骨粗鬆症治療／予防剤
JP2018215152A Pending JP2019023234A (ja) 2009-09-09 2018-11-16 骨粗鬆症治療剤ないし予防剤

Country Status (16)

Country Link
US (3) US20120252729A1 (enExample)
EP (3) EP2476429B1 (enExample)
JP (13) JPWO2011030774A1 (enExample)
KR (8) KR20190095552A (enExample)
CN (2) CN102470164B (enExample)
AU (1) AU2010293488B2 (enExample)
BR (1) BR112012003511A2 (enExample)
CA (1) CA2772656A1 (enExample)
ES (3) ES2663322T3 (enExample)
IL (1) IL217854A (enExample)
IN (1) IN2012DN00857A (enExample)
MX (1) MX335951B (enExample)
NZ (2) NZ598370A (enExample)
RU (1) RU2564894C2 (enExample)
WO (1) WO2011030774A1 (enExample)
ZA (1) ZA201201720B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101686271B1 (ko) * 2009-11-18 2016-12-13 아사히 가세이 파마 가부시키가이샤 인간 변형성 슬관절증의 예방제 및/또는 치료제 및/또는 악화 억제제
JP6235219B2 (ja) * 2013-03-21 2017-11-22 旭化成ファーマ株式会社 脊椎椎体間固定術後の骨癒合促進剤
US10394953B2 (en) 2015-07-17 2019-08-27 Facebook, Inc. Meme detection in digital chatter analysis
US20190381341A1 (en) * 2017-02-01 2019-12-19 The Johns Hopkins University Parathyroid hormone and regeneration of degenerative discs disease
US20200289621A1 (en) * 2017-09-22 2020-09-17 Asahi Kasei Pharma Corporation Teriparatide-containing liquid pharmaceutical composition having excellent stability
JP2019060866A (ja) * 2017-09-22 2019-04-18 旭化成ファーマ株式会社 液状医薬組成物の体内動態を予測する方法
CA3075984C (en) * 2017-09-22 2024-10-01 Asahi Kasei Pharma Corporation LIQUID PHARMACEUTICAL COMPOSITION CONTAINING TERIPARATIDE WITH EXCELLENT PHARMACOKINETIC AND/OR SAFETY PROPERTIES
ES3009869T3 (en) 2018-10-29 2025-03-31 Asahi Kasei Pharma Corp An improved teriparatide dosage regimen for use in preventing or treating osteoporosis characterized by administering teriparatide or salt thereof twice a week
KR102920552B1 (ko) * 2024-01-03 2026-01-30 김도영 나노입자경의 탄산칼슘과 탄산마그네슘 제조방법 및 그 방법으로 제조된 골다공증 예방치료제

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2505812B2 (ja) 1987-07-10 1996-06-12 旭化成工業株式会社 ｈ―ＰＴＨ（１―３４）凍結乾燥組成物
JP2662842B2 (ja) 1991-12-09 1997-10-15 旭化成工業株式会社 パラサイロイドホルモンの安定化組成物
JPH0873376A (ja) 1994-09-07 1996-03-19 Asahi Chem Ind Co Ltd 骨粗鬆症治療薬
SE9702401D0 (sv) * 1997-06-19 1997-06-19 Astra Ab Pharmaceutical use
ZA9811127B (en) * 1997-12-09 2000-07-11 Lilly Co Eli Stabilized teriparatide solutions.
DZ2873A1 (fr) * 1998-08-19 2003-12-15 Lilly Co Eli Procédé pour augmenter la dureté et la rigidité osseuse.
US6756480B2 (en) * 2000-04-27 2004-06-29 Amgen Inc. Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
NZ523457A (en) 2000-06-30 2004-11-26 Daiichi Suntory Pharma Co Composition for stimulating bone formation comprising hPTH in which the acetic acid component is low enough for administration to the nasal mucosa
JP5042419B2 (ja) * 2001-08-15 2012-10-03 旭化成ファーマ株式会社 骨形成促進剤および骨形成促進組成物
JP4931306B2 (ja) 2001-09-27 2012-05-16 旭化成ファーマ株式会社 骨形成を安全に促進させる医薬複合剤
CN1816324A (zh) * 2003-07-04 2006-08-09 尼克麦德丹麦公司 口服用的含甲状旁腺激素(pth)的药物组合物
WO2005102381A1 (ja) * 2004-04-26 2005-11-03 Ono Pharmaceutical Co., Ltd. カテプシンｋ阻害薬およびpth類を併用することを特徴とする骨密度増加剤
CA2567056A1 (en) * 2004-05-10 2005-12-08 Nastech Pharmaceutical Company Inc. Compositions and methods for enhanced mucosal delivery of parathyroid hormone
JP2006241098A (ja) * 2005-03-04 2006-09-14 Univ Kurume 骨量減少症の予防または治療薬
ES2443581T3 (es) * 2006-02-09 2014-02-19 Biomimetic Therapeutics, Llc Composiciones y métodos para el tratamiento de hueso
DE102006043846A1 (de) * 2006-03-14 2007-09-20 Claudia Zours Wirbelsäulenorthesen
AU2007225056A1 (en) * 2006-03-15 2007-09-20 Alza Corporation Apparatus and method for transdermal delivery of parathyroid hormone agents to prevent or treat osteopenia
CN101274961A (zh) * 2006-03-30 2008-10-01 天津医科大学 重组人甲状旁腺素相关蛋白
CN101125201A (zh) * 2006-08-17 2008-02-20 石家庄欧意药业有限公司 治疗骨质疏松症或防治由于骨质疏松而导致的骨折的药物组合物及其应用
CN101307105B (zh) * 2008-04-28 2012-08-29 中国药科大学 一种能串联表达和同步酸水解释放的人甲状旁腺素1-34肽类似物及其制备方法和应用

Similar Documents

Publication Publication Date Title
JP2017105859A5 (enExample)
JP2017105862A5 (enExample)
JP2017105861A5 (enExample)
WO2014205229A8 (en) Use of high dose pridopidine for treating huntington's disease
JP2016528301A5 (enExample)
JP2014240439A5 (enExample)
NZ714963A (en) Compositions and methods for treating anemia
RU2016105581A (ru) Способ лечения острого, хронического и подострого кашля и непреодолимого желания откашляться
JP2018513107A5 (enExample)
JP2016534142A5 (enExample)
JP2016510326A5 (enExample)
EA201492010A1 (ru) Применение высокой дозы лахинимода для лечения рассеянного склероза
JP2018513188A5 (enExample)
JP2017533972A5 (enExample)
WO2017022962A8 (ko) Ripk 억제제를 유효성분으로 포함하는 면역질환의 예방 또는 치료용 조성물
JP2015505564A5 (enExample)
EA201891931A1 (ru) Новые ингибиторы фосфатидилинозитол-3-киназы гамма
JP2020524689A5 (enExample)
SI2413933T1 (en) 2,4,6-TRIUFLORO-N- (6- (1-METHYL-PIPERIDIN-4-CARBONYL) -PYRIDIN-2-YL)-BENZAMIDE FOR THRESHOLD OF MIGRINE OVER ORAL OR INTRAVEN
JP2021503483A5 (enExample)
RU2020120156A (ru) Лечение приливов и потери костной ткани, вызванных андрогенной депривационной терапией с применением цис-кломифена
JP2019529569A5 (enExample)
MX2018013475A (es) Acido carboxilico para tratar/prevenir congestion nasal.
EP4470625A3 (en) A pharmaceutical composition comprising a combination of probiotic and prebiotic to treat stunting
UA122336C2 (uk) Бісамідна похідна дикарбонової кислоти як засіб, що стимулює регенерацію тканин і відновлення знижених функцій тканин